Based on several studies, inhibition of Nrf2 leads to decreasing HIF-1α protein levels in colon cancer through stimulating proteasomal degradation and the suppression of glucose uptake in colon cancer cells [159]. This evidence concerns the gene HIF1A and malignant colon neoplasm.